UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018504
Receipt number R000021412
Scientific Title Development of new diagnostic methods using 5-ALA for tissue stump and lymph node metastasis of gastric cancer
Date of disclosure of the study information 2015/07/31
Last modified on 2017/08/01 12:25:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of new diagnostic methods using 5-ALA for tissue stump and lymph node metastasis of gastric cancer

Acronym

New diagnostic methods using 5-ALA for gastric cancer

Scientific Title

Development of new diagnostic methods using 5-ALA for tissue stump and lymph node metastasis of gastric cancer

Scientific Title:Acronym

New diagnostic methods using 5-ALA for gastric cancer

Region

Japan


Condition

Condition

gastric cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate a real time diagnostic performance of lymph node metastasis of gastric cancer using 5-aminolevulinic acid.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase II


Assessment

Primary outcomes

Sensitivity and specificity of lymph node metastasis using fluorescence diagnostics

Key secondary outcomes

The comparison to the difference in fluorescence between normal and metastatic lymph nodes,
Positive predictive value,
Negative predictive value


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients have a malignant tumor lesions in the stomach
Patients who provided signed informed consent

Key exclusion criteria

Porphyria
Patients with a history of hypersensitivity of 5-ALA or porphyrins
Patients taking drugs that may cause photosensitivity (tetracycline antibiotics, sulfonamide-based formulation, new quinolone antibiotics, hypericin, St. John's wort-containing foods, etc)
Patients who is or might be pregnant
Patients who is determined inappropriate to participate in the study by the attending physician

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Eigo Otsuji

Organization

Kyoto Prefectural University of Medicine

Division name

Division of Digestive Surgery, Department of Surgery

Zip code


Address

465 Kajii-cho, Kamigyo-ku Kyoto 6028566 JAPAN

TEL

075-251-5527

Email

otsuji@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yasutosi Murayama

Organization

Kyoto Prefectural University of Medicine

Division name

Division of Digestive Surgery, Department of Surgery

Zip code


Address

465 Kajii-cho, Kamigyo-ku Kyoto 6028566 JAPAN

TEL

075-251-5527

Homepage URL

http://www.kpu-m.ac.jp/

Email

murayama@koto.kpu-m.ac.jp


Sponsor or person

Institute

Kyoto Prefectural University of Medicine

Institute

Department

Personal name



Funding Source

Organization

Ushio Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor

Ushio Ltd.

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都府立医科大学附属病院 (京都府)


Other administrative information

Date of disclosure of the study information

2015 Year 07 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2015 Year 05 Month 31 Day

Date of IRB


Anticipated trial start date

2015 Year 08 Month 01 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry

2021 Year 03 Month 31 Day

Date trial data considered complete

2021 Year 03 Month 31 Day

Date analysis concluded

2021 Year 03 Month 31 Day


Other

Other related information

In addition, we observe the fluorescence image of the stump of gastric resection.


Management information

Registered date

2015 Year 07 Month 31 Day

Last modified on

2017 Year 08 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021412


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name